140 related articles for article (PubMed ID: 8527119)
1. Inactivation of DNA by beta-propiolactone.
Perrin P; Morgeaux S
Biologicals; 1995 Sep; 23(3):207-11. PubMed ID: 8527119
[TBL] [Abstract][Full Text] [Related]
2. Beta-propiolactone treatment impairs the biological activity of residual DNA from BHK-21 cells infected with rabies virus.
Morgeaux S; Tordo N; Gontier C; Perrin P
Vaccine; 1993; 11(1):82-90. PubMed ID: 8427040
[TBL] [Abstract][Full Text] [Related]
3. Evaluation by polymerase chain reaction on the effect of beta-propiolactone and binary ethyleneimine on DNA.
Groseil C; Guerin P; Adamowicz P
Biologicals; 1995 Sep; 23(3):213-20. PubMed ID: 8527120
[TBL] [Abstract][Full Text] [Related]
4. Beta-Propiolactone Inactivation of Coxsackievirus A16 Induces Structural Alteration and Surface Modification of Viral Capsids.
Fan C; Ye X; Ku Z; Kong L; Liu Q; Xu C; Cong Y; Huang Z
J Virol; 2017 Apr; 91(8):. PubMed ID: 28148783
[TBL] [Abstract][Full Text] [Related]
5. Concentration-dependent mutation by alkylating agents in human lymphoblasts and Salmonella typhimurium: N-methyl-N-nitrosourethane and beta-propiolactone.
Penman BW; Hoppe H; Thilly WG
J Natl Cancer Inst; 1979 Oct; 63(4):903-7. PubMed ID: 384009
[TBL] [Abstract][Full Text] [Related]
6. Kinetics of induction of DNA damage and lacZ gene mutations in stomach mucosa of mice treated with beta-propiolactone and N-methyl-N'-nitro-N-nitrosoguanidine, using single-cell gel electrophoresis and MutaMouse models.
Brault D; Renault D; Tombolan F; Thybaud V
Environ Mol Mutagen; 1999; 34(2-3):182-9. PubMed ID: 10529742
[TBL] [Abstract][Full Text] [Related]
7. Treatment of influenza virus with beta-propiolactone alters viral membrane fusion.
Bonnafous P; Nicolaï MC; Taveau JC; Chevalier M; Barrière F; Medina J; Le Bihan O; Adam O; Ronzon F; Lambert O
Biochim Biophys Acta; 2014 Jan; 1838(1 Pt B):355-63. PubMed ID: 24140008
[TBL] [Abstract][Full Text] [Related]
8. The effect of chemical inactivation of bovine viral diarrhea virus with beta-propiolactone and binary ethyleneimine on plasma proteins and coagulation factors.
Refaie FM; Esmat AY; Mohamed AF; Mohamed WA
Egypt J Immunol; 2004; 11(2):9-20. PubMed ID: 16734113
[TBL] [Abstract][Full Text] [Related]
9. Effect of the β-propiolactone treatment on the adsorption and fusion of influenza A/Brisbane/59/2007 and A/New Caledonia/20/1999 virus H1N1 on a dimyristoylphosphatidylcholine/ganglioside GM3 mixed phospholipids monolayer at the air-water interface.
Desbat B; Lancelot E; Krell T; Nicolaï MC; Vogel F; Chevalier M; Ronzon F
Langmuir; 2011 Nov; 27(22):13675-83. PubMed ID: 21981550
[TBL] [Abstract][Full Text] [Related]
10. β-Propiolactone (BPL)-inactivation of SARS-Co-V-2: In vitro validation with focus on saliva from COVID-19 patients for scent dog training.
Pilchová V; Prajeeth CK; Jendrny P; Twele F; Meller S; Pink I; Fathi A; Addo MM; Volk HA; Osterhaus A; von Köckritz-Blickwede M; Schulz C
J Virol Methods; 2023 Jul; 317():114733. PubMed ID: 37068591
[TBL] [Abstract][Full Text] [Related]
11. Analysis of the beta-propiolactone sensitivity and optimization of inactivation methods for human influenza H3N2 virus.
Sasaki Y; Yoshino N; Sato S; Muraki Y
J Virol Methods; 2016 Sep; 235():105-111. PubMed ID: 27142111
[TBL] [Abstract][Full Text] [Related]
12. The role of specific IgE and beta-propiolactone in reactions resulting from booster doses of human diploid cell rabies vaccine.
Anderson MC; Baer H; Frazier DJ; Quinnan GV
J Allergy Clin Immunol; 1987 Dec; 80(6):861-8. PubMed ID: 3693763
[TBL] [Abstract][Full Text] [Related]
13. Inactivation of viruses by beta-propiolactone in human cryo poor plasma and IgG concentrates.
Scheidler A; Rokos K; Reuter T; Ebermann R; Pauli G
Biologicals; 1998 Jun; 26(2):135-44. PubMed ID: 9811521
[TBL] [Abstract][Full Text] [Related]
14. Alkylating agent and chromatin structure determine sequence context-dependent formation of alkylpurines.
Cloutier JF; Castonguay A; O'Connor TR; Drouin R
J Mol Biol; 2001 Feb; 306(2):169-88. PubMed ID: 11237592
[TBL] [Abstract][Full Text] [Related]
15. Anomalous cross-linking by mechlorethamine of DNA duplexes containing C-C mismatch pairs.
Romero RM; Mitas M; Haworth IS
Biochemistry; 1999 Mar; 38(12):3641-8. PubMed ID: 10090751
[TBL] [Abstract][Full Text] [Related]
16. [Principles of selective inactivation of the viral genome. III. Kinetics of the inactivation of bacteriophage MS2 infectivity by beta-propiolactone].
Budovskiĭ EI; Zalesskaia MA
Mol Biol (Mosk); 1985; 19(4):1139-47. PubMed ID: 4047036
[TBL] [Abstract][Full Text] [Related]
17. Validation of betapropiolactone (BPL) as an inactivant for infectious bovine rhinotracheitis (IBR) virus.
Kamaraj G; Lakshmi Narasu M; Srinivasan VA
Res Vet Sci; 2008 Dec; 85(3):589-94. PubMed ID: 18262212
[TBL] [Abstract][Full Text] [Related]
18. Intermolecular linking and fragmentation of DNA by beta-propiolactone, a monoalkylating carcinogen.
Kubinski H; Szybalski EH
Chem Biol Interact; 1975 Jan; 10(1):41-55. PubMed ID: 1090389
[TBL] [Abstract][Full Text] [Related]
19. Alterations in Bacillus subtilis transforming DNA induced by beta-propiolactone and 1,3-propane sultone, two mutagenic and carcinogenic alkylating agents.
Kubinski ZO; Kubinski H
J Bacteriol; 1978 Dec; 136(3):854-66. PubMed ID: 102637
[TBL] [Abstract][Full Text] [Related]
20. Quantitative determination of the infectivity of the proviral DNA of a retrovirus in vitro: Evaluation of methods for DNA inactivation.
Sheng-Fowler L; Lewis AM; Peden K
Biologicals; 2009 Aug; 37(4):259-69. PubMed ID: 19457682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
